Pharmaceuticals Companies By Held By Institutions

Shares Owned By Institutions
Shares Owned By InstitutionsEfficiencyMarket RiskExp Return
1JAZZ Jazz Pharmaceuticals PLC
99.9
 0.01 
 1.82 
 0.02 
2TERN Terns Pharmaceuticals
99.75
(0.23)
 3.79 
(0.86)
3PRGO Perrigo Company PLC
99.66
 0.08 
 3.04 
 0.23 
4PAHC Phibro Animal Health
99.41
 0.04 
 3.24 
 0.11 
5ELAN Elanco Animal Health
99.13
(0.08)
 2.17 
(0.18)
6PBH Prestige Brand Holdings
99.0
 0.08 
 2.36 
 0.20 
7INVA Innoviva
98.94
 0.08 
 0.98 
 0.08 
8EYPT Eyepoint Pharmaceuticals
98.85
(0.03)
 5.01 
(0.16)
9COLL Collegium Pharmaceutical
97.8
 0.03 
 2.64 
 0.09 
10HRMY Harmony Biosciences Holdings
97.68
 0.00 
 3.02 
 0.01 
11ANIP ANI Pharmaceuticals
97.41
 0.16 
 2.52 
 0.41 
12FULC Fulcrum Therapeutics
97.17
(0.19)
 3.49 
(0.66)
13PHAT Phathom Pharmaceuticals
97.01
(0.02)
 5.87 
(0.14)
14PCRX Pacira BioSciences,
96.82
 0.17 
 2.84 
 0.49 
15ITCI Intracellular Th
96.69
 0.18 
 4.76 
 0.84 
16ZTS Zoetis Inc
95.67
 0.02 
 1.64 
 0.03 
17SUPN Supernus Pharmaceuticals
95.0
(0.07)
 2.67 
(0.18)
18TBPH Theravance Biopharma
93.63
 0.00 
 2.62 
 0.01 
19ELVN Enliven Therapeutics
93.58
(0.01)
 3.43 
(0.04)
20RAPP Rapport Therapeutics, Common
93.47
(0.08)
 8.64 
(0.69)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen. Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.